Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lidocaine For Neuroprotection During Cardiac Surgery

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
CAS Medical Systems, Inc.
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00938964
First received: July 10, 2009
Last updated: August 24, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2017
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)